These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 15500572

  • 1. Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs.
    Kukanich B, Papich MG.
    J Vet Pharmacol Ther; 2004 Oct; 27(5):337-41. PubMed ID: 15500572
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological profile of dextrorphan.
    Fossati A, Vimercati MG, Caputo R, Valenti M.
    Arzneimittelforschung; 1995 Nov; 45(11):1188-93. PubMed ID: 8929237
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of tramadol and the metabolite O-desmethyltramadol in dogs.
    KuKanich B, Papich MG.
    J Vet Pharmacol Ther; 2004 Aug; 27(4):239-46. PubMed ID: 15305853
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance.
    Borges S, Li L, Hamman MA, Jones DR, Hall SD, Gorski JC.
    Drug Metab Dispos; 2005 Jul; 33(7):1052-5. PubMed ID: 15821042
    [Abstract] [Full Text] [Related]

  • 14. Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application.
    Dickinson GL, Rezaee S, Proctor NJ, Lennard MS, Tucker GT, Rostami-Hodjegan A.
    J Clin Pharmacol; 2007 Feb; 47(2):175-86. PubMed ID: 17244768
    [Abstract] [Full Text] [Related]

  • 15. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M, Lees P, Seewald W, King JN.
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral administration of dextromethorphan does not produce neuronal vacuolation in the rat brain.
    Carliss RD, Radovsky A, Chengelis CP, O'Neill TP, Shuey DL.
    Neurotoxicology; 2007 Jul; 28(4):813-8. PubMed ID: 17573115
    [Abstract] [Full Text] [Related]

  • 18. Novel single-point plasma or saliva dextromethorphan method for determining CYP2D6 activity.
    Hu OY, Tang HS, Lane HY, Chang WH, Hu TM.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):955-60. PubMed ID: 9618394
    [Abstract] [Full Text] [Related]

  • 19. Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors.
    Hernandez SC, Bertolino M, Xiao Y, Pringle KE, Caruso FS, Kellar KJ.
    J Pharmacol Exp Ther; 2000 Jun; 293(3):962-7. PubMed ID: 10869398
    [Abstract] [Full Text] [Related]

  • 20. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ, Diringer K, Russell T, Venkatakrishnan K, Wilner K, Crownover PH, Benincosa LJ, Gibbs MA.
    Clin Pharmacokinet; 2006 Jun; 45(10):989-1001. PubMed ID: 16984212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.